Alfuzosin hydrochloride
Alfuzosin hydrochloride is listed in the FDA National Drug Code directory with 5 NDC codes, marketed under brand name including Alfuzosin hydrochloride. Available dosage form: tablet, extended release.
Drug details
- Generic Name
- Alfuzosin hydrochloride
- Brand Names
- Alfuzosin hydrochloride
- Application Number
- ANDA203192
- Sponsor
- Bryant Ranch Prepack
- NDC Codes
- 5
- Dosage Forms
- TABLET, EXTENDED RELEASE
- Routes
- ORAL
- Active Ingredients
- ALFUZOSIN HYDROCHLORIDE
Indications and Usage
1 INDICATIONS AND USAGE Alfuzosin hydrochloride extended-release tablets, USP are indicated for the treatment of signs and symptoms of benign prostatic hyperplasia. Alfuzosin hydrochloride extended-release tablet is an alpha adrenergic antagonist, indicated for the treatment of signs and symptoms of benign prostatic hyperplasia. (1) Important Limitations of Use: Alfuzosin hydrochloride extended-release tablets are not indicated for treatment of hypertension. ( 1.1 ) Alfuzosin hydrochloride extended-release tablets are not indicated for use in the pediatric population. ( 1.1 , 8.4 , 12.3 ) 1.1 Important Limitations of Use Alfuzosin hydrochloride extended-release tablets, USP are not indicated for the treatment of hypertension. Alfuzosin hydrochloride extended-release tablets, USP are not indicated for use in the pediatric population.
1.1 Important Limitations of Use Alfuzosin hydrochloride extended-release tablets, USP are not indicated for the treatment of hypertension. Alfuzosin hydrochloride extended-release tablets, USP are not indicated for use in the pediatric population.